Asghar Najjam 4
4 · Sorrento Therapeutics, Inc. · Filed Mar 17, 2021
Insider Transaction Report
Form 4
Asghar Najjam
Chief Financial Officer
Transactions
- Award
Stock Option
2021-03-16+100,000→ 100,000 totalExercise: $10.18Exp: 2031-03-16→ Common Stock (100,000 underlying) - Award
Common Stock
2021-03-16+56,974→ 56,974 total
Footnotes (2)
- [F1]The reported securities are represented by restricted stock units, 1/4th of which shall vest on March 16, 2022 and 1/4th of which shall vest on each anniversary thereafter.
- [F2]1/4th of the original number of shares subject to the option shall vest on March 16, 2022, and 1/48th of the original number of shares subject to the option shall vest on a monthly basis thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.